{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "5156cf51-815b-4027-8548-7c6654654442",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from easse.annotation.sentence_level import SentenceOperationAnnotator"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "767d4851-1258-4c57-ba39-6dc4d8e08105",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_colwidth', 0)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1184a19d-01bb-400f-b9bf-5430329b2584",
   "metadata": {},
   "source": [
    "# Automatic Labelling of Sentence-level Simplification Operations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "7a8a208c-b350-48f8-a391-47947fd1d30b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def identify_simplification_operations(df, orig_col='original', simp_col='simplification', tokenizer='moses', lowercase=False):\n",
    "    sent_simop_annot = SentenceOperationAnnotator(tokenizer=tokenizer, lowercase=lowercase)\n",
    "    dataset_labels = sent_simop_annot.identify_operations(df[orig_col].values, df[simp_col].values)\n",
    "    \n",
    "    labels = {'compression': [], 'paraphrasing': [], 'splitting': [], 'addition': []}\n",
    "    for sent_labels in dataset_labels:\n",
    "        labels['addition'].append(int('A' in sent_labels or 'B-A' in sent_labels))\n",
    "        labels['compression'].append(int('D' in sent_labels or 'B-D' in sent_labels))\n",
    "        labels['paraphrasing'].append(int('R' in sent_labels or 'B-R' in sent_labels))\n",
    "        labels['splitting'].append(int('S' in sent_labels))\n",
    "        \n",
    "    df['addition'] = labels['addition']\n",
    "    df['compression'] = labels['compression']\n",
    "    df['paraphrasing'] = labels['paraphrasing']\n",
    "    df['splitting'] = labels['splitting']\n",
    "    \n",
    "    df['none'] = (df[orig_col] == df[simp_col]).astype(int)\n",
    "    df['unidentified'] = ((df['compression'] + df['paraphrasing'] + df['splitting'] + df['addition'] + df['none']) == 0).astype(int)\n",
    "    \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "8dd37cc5-e218-40b2-8fa0-ac417a9f34de",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_simpletico = pd.read_excel('dataset/SimpTICO-19 - Spanish - Test.xls')[['stringID', 'original', 'simplification', 'comments']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "16818dfb-1c34-467f-a9da-519120c354da",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_simpletico['no_simplification'] = df_simpletico['comments'] == 'NS'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "271c73e0-a6d5-4d6c-a9be-5e25a3aa3964",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>stringID</th>\n",
       "      <th>original</th>\n",
       "      <th>simplification</th>\n",
       "      <th>comments</th>\n",
       "      <th>no_simplification</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>PubMed_7:221</td>\n",
       "      <td>El tiempo promedio desde la aparición hasta la muerte era de  9,5 días (entre 4,8 y 13).</td>\n",
       "      <td>El tiempo promedio desde la aparición hasta la muerte era de  9,5 días (entre 4,8 y 13).</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>PubMed_7:249</td>\n",
       "      <td>El SARS-CoV y el MERS-CoV pueden sobrevivir in vitro durante 48 horas en un ambiente seco y hasta 5 días a menos de 20 °C con una humedad del 40-50 %.</td>\n",
       "      <td>El SARS-CoV y el MERS-CoV pueden sobrevivir in vitro durante 48 horas en un ambiente seco y hasta 5 días a menos de 20 °C con una humedad del 40-50 %.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Wikisource_2:2162</td>\n",
       "      <td>Estas son las medidas que creemos necesarias para apoyarnos mutuamente a fin de poder continuar trabajando, darle a nuestro movimiento el apoyo necesario y brindarle al mundo el servicio en el que confía.</td>\n",
       "      <td>Estas son las medidas que creemos necesarias para apoyarnos mutuamente a fin de poder continuar trabajando, darle a nuestro movimiento el apoyo necesario y brindarle al mundo el servicio en el que confía.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Wikipedia_handpicked_1:1491</td>\n",
       "      <td>En respuesta a un brote en desarrollo en Irán, la OMS envió allí a un equipo de misión conjunta para evaluar la situación. El 28 de febrero, funcionarios de la OMS dijeron que la evaluación de la amenaza por coronavirus a nivel mundial se elevaría de \"alta\" a \"muy alta\", su nivel más alto de alerta y evaluación del riesgo.</td>\n",
       "      <td>En respuesta a un brote en desarrollo en Irán, la OMS envió allí a un equipo de misión conjunta para evaluar la situación. El 28 de febrero, funcionarios de la OMS dijeron que la evaluación de la amenaza por coronavirus a nivel mundial se elevaría de \"alta\" a \"muy alta\", su nivel más alto de alerta y evaluación del riesgo.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>PubMed_11:1054</td>\n",
       "      <td>Es necesario actualizar los criterios de diagnóstico de los “casos sospechosos” y “casos confirmados” de COVID-19</td>\n",
       "      <td>Es necesario actualizar los criterios de diagnóstico de los “casos sospechosos” y “casos confirmados” de COVID-19</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2129</th>\n",
       "      <td>Wikipedia_handpicked_7:2039</td>\n",
       "      <td>La Organización Mundial de la Salud (OMS) recomienda que los pacientes que ingresan se separen en distintas salas de espera en función de si se sospecha o no que puedan tener COVID-19. Además de otros tipos de equipos de protección personal, la OSHA recomienda el uso de mascarillas para aquellas personas que trabajen a una distancia de hasta 6 pies de los pacientes que se hayan contagiado o se sospeche que se han contagiado de SARS-CoV-2 y para aquellos que realicen procedimientos de generación de aerosoles.</td>\n",
       "      <td>La Organización Mundial de la Salud recomienda que los pacientes que ingresan se separen en distintas salas de espera si se sospecha o no que puedan tener COVID-19. Además de otros tipos de equipos de protección personal, la OSHA recomienda el uso de mascarillas para aquellas personas que trabajen a una distancia, de hasta 6 pies, de los pacientes que se hayan contagiado o se sospeche que se han contagiado de SARS-CoV-2. También para aquellos que realicen procedimientos de generación de aerosoles.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2130</th>\n",
       "      <td>Wikipedia_handpicked_7:2040</td>\n",
       "      <td>En los Estados Unidos, se deben usar respiradores N95 con mascarilla de filtrado aprobados por NIOSH o superiores en el contexto de un programa respiratorio integral escrito que incluya pruebas de ajuste, capacitaciones y exámenes médicos.</td>\n",
       "      <td>En los Estados Unidos, se deben usar respiradores N95 con mascarilla de filtrado aprobados por NIOSH, o superiores, en el contexto de un programa respiratorio integral escrito que incluya pruebas de ajuste, capacitaciones y exámenes médicos.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2131</th>\n",
       "      <td>Wikipedia_handpicked_7:2041</td>\n",
       "      <td>Otros tipos de mascarillas pueden brindar una mayor protección y mejorar la comodidad del trabajador. La OMS no recomienda el uso de monos protectores, ya que la COVID-19 es una enfermedad respiratoria, no una que se transmita por los fluidos corporales.</td>\n",
       "      <td>Otros tipos de mascarillas pueden brindar una mayor protección y mejorar la comodidad del trabajador. La OMS no recomienda el uso de monos protectores, ya que la COVID-19 es una enfermedad respiratoria y no se transmite por los fluidos corporales.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2132</th>\n",
       "      <td>Wikipedia_handpicked_7:2043</td>\n",
       "      <td>Para aquellos que tomen muestras respiratorias de pacientes con COVID-19, les brinden atención o los transporten sin realizar procedimientos de generación de aerosoles, la OMS recomienda el uso de mascarilla quirúrgica, gafas o protector facial, bata y guantes.</td>\n",
       "      <td>Para aquellos que tomen muestras respiratorias de pacientes con COVID-19, les atiendan o los transporten sin realizar procedimientos de generación de aerosoles, la OMS recomienda el uso de mascarilla quirúrgica, gafas o protector facial, bata y guantes.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2133</th>\n",
       "      <td>Wikipedia_handpicked_7:2045</td>\n",
       "      <td>Debido a que el suministro de equipos de protección personal es insuficiente, la OMS recomienda minimizar la necesidad de usarlos, reemplazándolos por la telemedicina, las barreras físicas tales como ventanas transparentes, la limitación del permiso de ingreso a la habitación de un paciente con COVID-19 solo a aquellas personas involucradas en su atención directa, el uso de una misma mascarilla sin retirarla mientras se brinda atención a varios pacientes con el mismo diagnóstico, el monitoreo y la coordinación de la cadena de suministro de equipos de protección personal y desalentar el uso de mascarillas por parte de personas asintomáticas.</td>\n",
       "      <td>Debido a que el suministro de equipos de protección personal es insuficiente, la OMS recomienda minimizar la necesidad de usarlos, reemplazándolos por la telemedicina, las barreras físicas como ventanas transparentes, la limitación del permiso de ingreso a la habitación de un paciente con COVID-19 solo a las personas involucradas en su atención directa, el uso de una misma mascarilla sin retirarla mientras se atiende a varios pacientes con el mismo diagnóstico, el monitoreo y la coordinación de la cadena de suministro de equipos de protección personal y desalentar el uso de mascarillas por parte de personas asintomáticas.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2134 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                         stringID  \\\n",
       "0     PubMed_7:221                  \n",
       "1     PubMed_7:249                  \n",
       "2     Wikisource_2:2162             \n",
       "3     Wikipedia_handpicked_1:1491   \n",
       "4     PubMed_11:1054                \n",
       "...              ...                \n",
       "2129  Wikipedia_handpicked_7:2039   \n",
       "2130  Wikipedia_handpicked_7:2040   \n",
       "2131  Wikipedia_handpicked_7:2041   \n",
       "2132  Wikipedia_handpicked_7:2043   \n",
       "2133  Wikipedia_handpicked_7:2045   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      original  \\\n",
       "0     El tiempo promedio desde la aparición hasta la muerte era de  9,5 días (entre 4,8 y 13).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "1     El SARS-CoV y el MERS-CoV pueden sobrevivir in vitro durante 48 horas en un ambiente seco y hasta 5 días a menos de 20 °C con una humedad del 40-50 %.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "2     Estas son las medidas que creemos necesarias para apoyarnos mutuamente a fin de poder continuar trabajando, darle a nuestro movimiento el apoyo necesario y brindarle al mundo el servicio en el que confía.                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3     En respuesta a un brote en desarrollo en Irán, la OMS envió allí a un equipo de misión conjunta para evaluar la situación. El 28 de febrero, funcionarios de la OMS dijeron que la evaluación de la amenaza por coronavirus a nivel mundial se elevaría de \"alta\" a \"muy alta\", su nivel más alto de alerta y evaluación del riesgo.                                                                                                                                                                                                                                                                                                                                       \n",
       "4     Es necesario actualizar los criterios de diagnóstico de los “casos sospechosos” y “casos confirmados” de COVID-19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "...                                                                                                                 ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "2129  La Organización Mundial de la Salud (OMS) recomienda que los pacientes que ingresan se separen en distintas salas de espera en función de si se sospecha o no que puedan tener COVID-19. Además de otros tipos de equipos de protección personal, la OSHA recomienda el uso de mascarillas para aquellas personas que trabajen a una distancia de hasta 6 pies de los pacientes que se hayan contagiado o se sospeche que se han contagiado de SARS-CoV-2 y para aquellos que realicen procedimientos de generación de aerosoles.                                                                                                                                          \n",
       "2130  En los Estados Unidos, se deben usar respiradores N95 con mascarilla de filtrado aprobados por NIOSH o superiores en el contexto de un programa respiratorio integral escrito que incluya pruebas de ajuste, capacitaciones y exámenes médicos.                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "2131  Otros tipos de mascarillas pueden brindar una mayor protección y mejorar la comodidad del trabajador. La OMS no recomienda el uso de monos protectores, ya que la COVID-19 es una enfermedad respiratoria, no una que se transmita por los fluidos corporales.                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "2132  Para aquellos que tomen muestras respiratorias de pacientes con COVID-19, les brinden atención o los transporten sin realizar procedimientos de generación de aerosoles, la OMS recomienda el uso de mascarilla quirúrgica, gafas o protector facial, bata y guantes.                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2133  Debido a que el suministro de equipos de protección personal es insuficiente, la OMS recomienda minimizar la necesidad de usarlos, reemplazándolos por la telemedicina, las barreras físicas tales como ventanas transparentes, la limitación del permiso de ingreso a la habitación de un paciente con COVID-19 solo a aquellas personas involucradas en su atención directa, el uso de una misma mascarilla sin retirarla mientras se brinda atención a varios pacientes con el mismo diagnóstico, el monitoreo y la coordinación de la cadena de suministro de equipos de protección personal y desalentar el uso de mascarillas por parte de personas asintomáticas.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             simplification  \\\n",
       "0     El tiempo promedio desde la aparición hasta la muerte era de  9,5 días (entre 4,8 y 13).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1     El SARS-CoV y el MERS-CoV pueden sobrevivir in vitro durante 48 horas en un ambiente seco y hasta 5 días a menos de 20 °C con una humedad del 40-50 %.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "2     Estas son las medidas que creemos necesarias para apoyarnos mutuamente a fin de poder continuar trabajando, darle a nuestro movimiento el apoyo necesario y brindarle al mundo el servicio en el que confía.                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "3     En respuesta a un brote en desarrollo en Irán, la OMS envió allí a un equipo de misión conjunta para evaluar la situación. El 28 de febrero, funcionarios de la OMS dijeron que la evaluación de la amenaza por coronavirus a nivel mundial se elevaría de \"alta\" a \"muy alta\", su nivel más alto de alerta y evaluación del riesgo.                                                                                                                                                                                                                                                                                                                    \n",
       "4     Es necesario actualizar los criterios de diagnóstico de los “casos sospechosos” y “casos confirmados” de COVID-19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "...                                                                                                                 ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "2129  La Organización Mundial de la Salud recomienda que los pacientes que ingresan se separen en distintas salas de espera si se sospecha o no que puedan tener COVID-19. Además de otros tipos de equipos de protección personal, la OSHA recomienda el uso de mascarillas para aquellas personas que trabajen a una distancia, de hasta 6 pies, de los pacientes que se hayan contagiado o se sospeche que se han contagiado de SARS-CoV-2. También para aquellos que realicen procedimientos de generación de aerosoles.                                                                                                                                  \n",
       "2130  En los Estados Unidos, se deben usar respiradores N95 con mascarilla de filtrado aprobados por NIOSH, o superiores, en el contexto de un programa respiratorio integral escrito que incluya pruebas de ajuste, capacitaciones y exámenes médicos.                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "2131  Otros tipos de mascarillas pueden brindar una mayor protección y mejorar la comodidad del trabajador. La OMS no recomienda el uso de monos protectores, ya que la COVID-19 es una enfermedad respiratoria y no se transmite por los fluidos corporales.                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "2132  Para aquellos que tomen muestras respiratorias de pacientes con COVID-19, les atiendan o los transporten sin realizar procedimientos de generación de aerosoles, la OMS recomienda el uso de mascarilla quirúrgica, gafas o protector facial, bata y guantes.                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "2133  Debido a que el suministro de equipos de protección personal es insuficiente, la OMS recomienda minimizar la necesidad de usarlos, reemplazándolos por la telemedicina, las barreras físicas como ventanas transparentes, la limitación del permiso de ingreso a la habitación de un paciente con COVID-19 solo a las personas involucradas en su atención directa, el uso de una misma mascarilla sin retirarla mientras se atiende a varios pacientes con el mismo diagnóstico, el monitoreo y la coordinación de la cadena de suministro de equipos de protección personal y desalentar el uso de mascarillas por parte de personas asintomáticas.   \n",
       "\n",
       "     comments  no_simplification  \n",
       "0     NS       True               \n",
       "1     NS       True               \n",
       "2     NS       True               \n",
       "3     NS       True               \n",
       "4     NS       True               \n",
       "...   ..        ...               \n",
       "2129  NaN      False              \n",
       "2130  NaN      False              \n",
       "2131  NaN      False              \n",
       "2132  NaN      False              \n",
       "2133  NaN      False              \n",
       "\n",
       "[2134 rows x 5 columns]"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_simpletico"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "4482ceab-0b54-4bfa-a29b-32c20a5b779c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of the model checkpoint at bert-base-multilingual-cased were not used when initializing BertModel: ['cls.predictions.decoder.weight', 'cls.seq_relationship.weight', 'cls.predictions.transform.LayerNorm.bias', 'cls.predictions.transform.dense.bias', 'cls.predictions.bias', 'cls.predictions.transform.dense.weight', 'cls.predictions.transform.LayerNorm.weight', 'cls.seq_relationship.bias']\n",
      "- This IS expected if you are initializing BertModel from the checkpoint of a model trained on another task or with another architecture (e.g. initializing a BertForSequenceClassification model from a BertForPreTraining model).\n",
      "- This IS NOT expected if you are initializing BertModel from the checkpoint of a model that you expect to be exactly identical (initializing a BertForSequenceClassification model from a BertForSequenceClassification model).\n",
      "2022-04-21 14:31:47,696 - simalign.simalign - INFO - Initialized the EmbeddingLoader with model: bert-base-multilingual-cased\n",
      "2134it [07:50,  4.54it/s]\n"
     ]
    }
   ],
   "source": [
    "df_simpletico_with_labels = identify_simplification_operations(df_simpletico)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "66c35960-fe2e-4e97-85a0-696ac0a52b3f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>stringID</th>\n",
       "      <th>original</th>\n",
       "      <th>simplification</th>\n",
       "      <th>comments</th>\n",
       "      <th>no_simplification</th>\n",
       "      <th>addition</th>\n",
       "      <th>compression</th>\n",
       "      <th>paraphrasing</th>\n",
       "      <th>splitting</th>\n",
       "      <th>none</th>\n",
       "      <th>unidentified</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>CMU_1:97</td>\n",
       "      <td>siento dolor en el pecho</td>\n",
       "      <td>Siento dolor en el pecho</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>CMU_1:102</td>\n",
       "      <td>como presión arterial alta o diabetes</td>\n",
       "      <td>Como presión arterial alta o diabetes</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>CMU_1:117</td>\n",
       "      <td>desde que tiene fiebre</td>\n",
       "      <td>Desde que tiene fiebre</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>CMU_1:121</td>\n",
       "      <td>cuénteme sobre su dolor de pecho</td>\n",
       "      <td>Cuénteme sobre su dolor de pecho</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>CMU_1:136</td>\n",
       "      <td>¿dónde siente dolor en el pecho?</td>\n",
       "      <td>¿Dónde siente dolor en el pecho?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>CMU_1:141</td>\n",
       "      <td>dijo que siente este dolor de pecho</td>\n",
       "      <td>Dijo que siente este dolor de pecho</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>PubMed_7:219</td>\n",
       "      <td>En promedio, transcurrían 5 días (de 2 a 9) entre la aparición y el diagnóstico de la COVID-19.</td>\n",
       "      <td>En promedio, transcurrían 5 días (de 2 a 9) entre la aparición y el diagnóstico de la COVID-19.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>PubMed_7:222</td>\n",
       "      <td>El número reproductivo básico (R0) era de 3,77 (IC del 95 %: 3,51-4,05) y el R0 ajustado era de 2,23-4,82.</td>\n",
       "      <td>El número reproductivo básico (R0) era de 3,77 (IC del 95 %: 3,51-4,05) y el R0 ajustado era de 2,23-4,82.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>PubMed_7:238</td>\n",
       "      <td>El 18 de febrero de 2020, Zhou, et al., reveló la estructura de criomicroscopía electrónica de la ACE2 humana de longitud completa en resolución 2.9 Å, en complejo con el aminoácido transportador B0AT1.</td>\n",
       "      <td>El 18 de febrero de 2020, Zhou, et al., reveló la estructura de criomicroscopía electrónica de la ACE2 humana de longitud completa en resolución 2.9 Å, en complejo con el aminoácido transportador B0AT1.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>Wikipedia_handpicked_1:1229</td>\n",
       "      <td>Las estimaciones chinas de la proporción de personas asintomáticas oscilan de unas pocas a un 44 %.</td>\n",
       "      <td>Las estimaciones chinas de la proporción de personas asintomáticas oscilan de unas pocas a un 44 %.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>wiki_10:2559</td>\n",
       "      <td>Otras líneas de investigación incluyen el desarrollo de una vacuna contra la COVID-19 y transfusión de plasma de convaleciente. El SARS-CoV-2 tiene aproximadamente 66 proteínas quimiomodulables, cada una de las cuales tiene múltiples sitios de unión con el ligando.</td>\n",
       "      <td>Otras líneas de investigación incluyen el desarrollo de una vacuna contra la COVID-19 y transfusión de plasma de convaleciente. El SARS-CoV-2 tiene aproximadamente 66 proteínas quimiomodulables, cada una de las cuales tiene múltiples sitios de unión con el ligando.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>wiki_10:2573</td>\n",
       "      <td>Treinta y cinco pacientes en Shenzhen dieron negativo en un promedio de 4 días, mientras que la duración de la enfermedad fue de 11 días en 45 pacientes que no lo recibieron.</td>\n",
       "      <td>Treinta y cinco pacientes en Shenzhen dieron negativo en un promedio de 4 días, mientras que la duración de la enfermedad fue de 11 días en 45 pacientes que no lo recibieron.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>PubMed_7:255</td>\n",
       "      <td>En general, después de que el virus invade al huésped, primero es reconocido por el sistema inmunitario innato del huésped a través de los receptores de reconocimiento de patrones (PRR), incluidos los receptores de lectinas tipo C, los receptores tipo Toll (TLR), los receptores tipo NOD (NLR) y los receptores tipo RIG-I (RLR).</td>\n",
       "      <td>En general, después de que el virus invade al huésped, primero es reconocido por el sistema inmunitario innato del huésped a través de los receptores de reconocimiento de patrones (PRR), incluidos los receptores de lectinas tipo C, los receptores tipo Toll (TLR), los receptores tipo NOD (NLR) y los receptores tipo RIG-I (RLR).</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>PubMed_7:256</td>\n",
       "      <td>A través de distintas vías, el virus induce la expresión de factores inflamatorios, la maduración de las células dendríticas y la síntesis de los interferones tipo I (IFN) que limitan la propagación del virus y aceleran la fagocitosis macrofágica de los antígenos virales.</td>\n",
       "      <td>A través de distintas vías, el virus induce la expresión de factores inflamatorios, la maduración de las células dendríticas y la síntesis de los interferones tipo I (IFN) que limitan la propagación del virus y aceleran la fagocitosis macrofágica de los antígenos virales.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>PubMed_7:259</td>\n",
       "      <td>Los linfocitos T, incluidas las células T CD4+ y CD8+, cumplen una función importante en la defensa.</td>\n",
       "      <td>Los linfocitos T, incluidas las células T CD4+ y CD8+, cumplen una función importante en la defensa.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>Wikipedia_handpicked_3:1698</td>\n",
       "      <td>De los 16 laboratorios de referencia, 7 están en Asia, 5 en Europa, 2 en África, 1 en América del Norte y 1 en Australia.</td>\n",
       "      <td>De los 16 laboratorios de referencia, 7 están en Asia, 5 en Europa, 2 en África, 1 en América del Norte y 1 en Australia.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>CMU_1:60</td>\n",
       "      <td>¿ve la imagen?</td>\n",
       "      <td>¿Ve la imagen?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>CMU_1:65</td>\n",
       "      <td>¿cuánto tiene de fiebre?</td>\n",
       "      <td>¿Cuánto tiene de fiebre?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>CMU_1:66</td>\n",
       "      <td>¿cómo está su presión arterial?</td>\n",
       "      <td>¿Cómo está su presión arterial?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>CMU_1:35</td>\n",
       "      <td>¿tiene algún otro síntoma?</td>\n",
       "      <td>¿Tiene algún otro síntoma?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>CMU_1:56</td>\n",
       "      <td>¿tiene presión arterial alta?</td>\n",
       "      <td>¿Tiene presión arterial alta?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>CMU_1:58</td>\n",
       "      <td>¿sabe qué síntomas tenía?</td>\n",
       "      <td>¿Sabe qué síntomas tenía?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>Wikipedia_handpicked_1:1172</td>\n",
       "      <td>Alrededor de 364 000 personas se recuperaron.</td>\n",
       "      <td>Alrededor de 364 000 personas se recuperaron.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>wiki_20:2416</td>\n",
       "      <td>La ECA2 es una proteína de membrana unipaso de tipo I, con su dominio enzimáticamente activo expuesto en la superficie de las células de los pulmones y otros tejidos.</td>\n",
       "      <td>La ECA2 es una proteína de membrana unipaso de tipo I, con su dominio enzimáticamente activo expuesto en la superficie de las células de los pulmones y otros tejidos.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>wiki_20:2421</td>\n",
       "      <td>La ECA escinde la hormona de la angiotensina I y forma la angiotensina II, que es vasoconstrictora.</td>\n",
       "      <td>La ECA escinde la hormona de la angiotensina I y forma la angiotensina II, que es vasoconstrictora.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>wiki_20:2422</td>\n",
       "      <td>A su vez, la ECA2 escinde el aminoácido carboxilo-terminal fenilalanina de la angiotensina II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) y lo hidroliza para formar la angiotensina vasodilatadora (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).</td>\n",
       "      <td>A su vez, la ECA2 escinde el aminoácido carboxilo-terminal fenilalanina de la angiotensina II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) y lo hidroliza para formar la angiotensina vasodilatadora (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>466</th>\n",
       "      <td>wiki_4:2666</td>\n",
       "      <td>vector vírico (desarrollador de la fase I y posible vacuna: CanSino Biologics, vector de adenovirus tipo 5)</td>\n",
       "      <td>Vector vírico (desarrollador de la fase I y posible vacuna: CanSino Biologics, vector de adenovirus tipo 5)</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        stringID  \\\n",
       "30   CMU_1:97                      \n",
       "31   CMU_1:102                     \n",
       "32   CMU_1:117                     \n",
       "33   CMU_1:121                     \n",
       "34   CMU_1:136                     \n",
       "35   CMU_1:141                     \n",
       "36   PubMed_7:219                  \n",
       "37   PubMed_7:222                  \n",
       "41   PubMed_7:238                  \n",
       "55   Wikipedia_handpicked_1:1229   \n",
       "64   wiki_10:2559                  \n",
       "70   wiki_10:2573                  \n",
       "75   PubMed_7:255                  \n",
       "76   PubMed_7:256                  \n",
       "77   PubMed_7:259                  \n",
       "210  Wikipedia_handpicked_3:1698   \n",
       "223  CMU_1:60                      \n",
       "332  CMU_1:65                      \n",
       "333  CMU_1:66                      \n",
       "413  CMU_1:35                      \n",
       "439  CMU_1:56                      \n",
       "440  CMU_1:58                      \n",
       "452  Wikipedia_handpicked_1:1172   \n",
       "457  wiki_20:2416                  \n",
       "460  wiki_20:2421                  \n",
       "461  wiki_20:2422                  \n",
       "466  wiki_4:2666                   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                     original  \\\n",
       "30   siento dolor en el pecho                                                                                                                                                                                                                                                                                                                   \n",
       "31   como presión arterial alta o diabetes                                                                                                                                                                                                                                                                                                      \n",
       "32   desde que tiene fiebre                                                                                                                                                                                                                                                                                                                     \n",
       "33   cuénteme sobre su dolor de pecho                                                                                                                                                                                                                                                                                                           \n",
       "34   ¿dónde siente dolor en el pecho?                                                                                                                                                                                                                                                                                                           \n",
       "35   dijo que siente este dolor de pecho                                                                                                                                                                                                                                                                                                        \n",
       "36   En promedio, transcurrían 5 días (de 2 a 9) entre la aparición y el diagnóstico de la COVID-19.                                                                                                                                                                                                                                            \n",
       "37   El número reproductivo básico (R0) era de 3,77 (IC del 95 %: 3,51-4,05) y el R0 ajustado era de 2,23-4,82.                                                                                                                                                                                                                                 \n",
       "41   El 18 de febrero de 2020, Zhou, et al., reveló la estructura de criomicroscopía electrónica de la ACE2 humana de longitud completa en resolución 2.9 Å, en complejo con el aminoácido transportador B0AT1.                                                                                                                                 \n",
       "55   Las estimaciones chinas de la proporción de personas asintomáticas oscilan de unas pocas a un 44 %.                                                                                                                                                                                                                                        \n",
       "64   Otras líneas de investigación incluyen el desarrollo de una vacuna contra la COVID-19 y transfusión de plasma de convaleciente. El SARS-CoV-2 tiene aproximadamente 66 proteínas quimiomodulables, cada una de las cuales tiene múltiples sitios de unión con el ligando.                                                                  \n",
       "70   Treinta y cinco pacientes en Shenzhen dieron negativo en un promedio de 4 días, mientras que la duración de la enfermedad fue de 11 días en 45 pacientes que no lo recibieron.                                                                                                                                                             \n",
       "75   En general, después de que el virus invade al huésped, primero es reconocido por el sistema inmunitario innato del huésped a través de los receptores de reconocimiento de patrones (PRR), incluidos los receptores de lectinas tipo C, los receptores tipo Toll (TLR), los receptores tipo NOD (NLR) y los receptores tipo RIG-I (RLR).   \n",
       "76   A través de distintas vías, el virus induce la expresión de factores inflamatorios, la maduración de las células dendríticas y la síntesis de los interferones tipo I (IFN) que limitan la propagación del virus y aceleran la fagocitosis macrofágica de los antígenos virales.                                                           \n",
       "77   Los linfocitos T, incluidas las células T CD4+ y CD8+, cumplen una función importante en la defensa.                                                                                                                                                                                                                                       \n",
       "210  De los 16 laboratorios de referencia, 7 están en Asia, 5 en Europa, 2 en África, 1 en América del Norte y 1 en Australia.                                                                                                                                                                                                                  \n",
       "223  ¿ve la imagen?                                                                                                                                                                                                                                                                                                                             \n",
       "332  ¿cuánto tiene de fiebre?                                                                                                                                                                                                                                                                                                                   \n",
       "333  ¿cómo está su presión arterial?                                                                                                                                                                                                                                                                                                            \n",
       "413  ¿tiene algún otro síntoma?                                                                                                                                                                                                                                                                                                                 \n",
       "439  ¿tiene presión arterial alta?                                                                                                                                                                                                                                                                                                              \n",
       "440  ¿sabe qué síntomas tenía?                                                                                                                                                                                                                                                                                                                  \n",
       "452  Alrededor de 364 000 personas se recuperaron.                                                                                                                                                                                                                                                                                              \n",
       "457  La ECA2 es una proteína de membrana unipaso de tipo I, con su dominio enzimáticamente activo expuesto en la superficie de las células de los pulmones y otros tejidos.                                                                                                                                                                     \n",
       "460  La ECA escinde la hormona de la angiotensina I y forma la angiotensina II, que es vasoconstrictora.                                                                                                                                                                                                                                        \n",
       "461  A su vez, la ECA2 escinde el aminoácido carboxilo-terminal fenilalanina de la angiotensina II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) y lo hidroliza para formar la angiotensina vasodilatadora (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).                                                                                                       \n",
       "466  vector vírico (desarrollador de la fase I y posible vacuna: CanSino Biologics, vector de adenovirus tipo 5)                                                                                                                                                                                                                                \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                               simplification  \\\n",
       "30   Siento dolor en el pecho                                                                                                                                                                                                                                                                                                                   \n",
       "31   Como presión arterial alta o diabetes                                                                                                                                                                                                                                                                                                      \n",
       "32   Desde que tiene fiebre                                                                                                                                                                                                                                                                                                                     \n",
       "33   Cuénteme sobre su dolor de pecho                                                                                                                                                                                                                                                                                                           \n",
       "34   ¿Dónde siente dolor en el pecho?                                                                                                                                                                                                                                                                                                           \n",
       "35   Dijo que siente este dolor de pecho                                                                                                                                                                                                                                                                                                        \n",
       "36   En promedio, transcurrían 5 días (de 2 a 9) entre la aparición y el diagnóstico de la COVID-19.                                                                                                                                                                                                                                            \n",
       "37   El número reproductivo básico (R0) era de 3,77 (IC del 95 %: 3,51-4,05) y el R0 ajustado era de 2,23-4,82.                                                                                                                                                                                                                                 \n",
       "41   El 18 de febrero de 2020, Zhou, et al., reveló la estructura de criomicroscopía electrónica de la ACE2 humana de longitud completa en resolución 2.9 Å, en complejo con el aminoácido transportador B0AT1.                                                                                                                                 \n",
       "55   Las estimaciones chinas de la proporción de personas asintomáticas oscilan de unas pocas a un 44 %.                                                                                                                                                                                                                                        \n",
       "64   Otras líneas de investigación incluyen el desarrollo de una vacuna contra la COVID-19 y transfusión de plasma de convaleciente. El SARS-CoV-2 tiene aproximadamente 66 proteínas quimiomodulables, cada una de las cuales tiene múltiples sitios de unión con el ligando.                                                                  \n",
       "70   Treinta y cinco pacientes en Shenzhen dieron negativo en un promedio de 4 días, mientras que la duración de la enfermedad fue de 11 días en 45 pacientes que no lo recibieron.                                                                                                                                                             \n",
       "75   En general, después de que el virus invade al huésped, primero es reconocido por el sistema inmunitario innato del huésped a través de los receptores de reconocimiento de patrones (PRR), incluidos los receptores de lectinas tipo C, los receptores tipo Toll (TLR), los receptores tipo NOD (NLR) y los receptores tipo RIG-I (RLR).   \n",
       "76   A través de distintas vías, el virus induce la expresión de factores inflamatorios, la maduración de las células dendríticas y la síntesis de los interferones tipo I (IFN) que limitan la propagación del virus y aceleran la fagocitosis macrofágica de los antígenos virales.                                                           \n",
       "77   Los linfocitos T, incluidas las células T CD4+ y CD8+, cumplen una función importante en la defensa.                                                                                                                                                                                                                                       \n",
       "210  De los 16 laboratorios de referencia, 7 están en Asia, 5 en Europa, 2 en África, 1 en América del Norte y 1 en Australia.                                                                                                                                                                                                                  \n",
       "223  ¿Ve la imagen?                                                                                                                                                                                                                                                                                                                             \n",
       "332  ¿Cuánto tiene de fiebre?                                                                                                                                                                                                                                                                                                                   \n",
       "333  ¿Cómo está su presión arterial?                                                                                                                                                                                                                                                                                                            \n",
       "413  ¿Tiene algún otro síntoma?                                                                                                                                                                                                                                                                                                                 \n",
       "439  ¿Tiene presión arterial alta?                                                                                                                                                                                                                                                                                                              \n",
       "440  ¿Sabe qué síntomas tenía?                                                                                                                                                                                                                                                                                                                  \n",
       "452  Alrededor de 364 000 personas se recuperaron.                                                                                                                                                                                                                                                                                              \n",
       "457  La ECA2 es una proteína de membrana unipaso de tipo I, con su dominio enzimáticamente activo expuesto en la superficie de las células de los pulmones y otros tejidos.                                                                                                                                                                     \n",
       "460  La ECA escinde la hormona de la angiotensina I y forma la angiotensina II, que es vasoconstrictora.                                                                                                                                                                                                                                        \n",
       "461  A su vez, la ECA2 escinde el aminoácido carboxilo-terminal fenilalanina de la angiotensina II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) y lo hidroliza para formar la angiotensina vasodilatadora (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).                                                                                                       \n",
       "466  Vector vírico (desarrollador de la fase I y posible vacuna: CanSino Biologics, vector de adenovirus tipo 5)                                                                                                                                                                                                                                \n",
       "\n",
       "    comments  no_simplification  addition  compression  paraphrasing  \\\n",
       "30   NS       True               0         0            0              \n",
       "31   NS       True               0         0            0              \n",
       "32   NS       True               0         0            0              \n",
       "33   NS       True               0         0            0              \n",
       "34   NS       True               0         0            0              \n",
       "35   NS       True               0         0            0              \n",
       "36   NS       True               0         0            0              \n",
       "37   NS       True               0         0            0              \n",
       "41   NS       True               0         0            0              \n",
       "55   NS       True               0         0            0              \n",
       "64   NS       True               0         0            0              \n",
       "70   NS       True               0         0            0              \n",
       "75   NS       True               0         0            0              \n",
       "76   NS       True               0         0            0              \n",
       "77   NS       True               0         0            0              \n",
       "210  NS       True               0         0            0              \n",
       "223  NS       True               0         0            0              \n",
       "332  NS       True               0         0            0              \n",
       "333  NS       True               0         0            0              \n",
       "413  NS       True               0         0            0              \n",
       "439  NS       True               0         0            0              \n",
       "440  NS       True               0         0            0              \n",
       "452  NS       True               0         0            0              \n",
       "457  NS       True               0         0            0              \n",
       "460  NS       True               0         0            0              \n",
       "461  NS       True               0         0            0              \n",
       "466  NS       True               0         0            0              \n",
       "\n",
       "     splitting  none  unidentified  \n",
       "30   0          0     1             \n",
       "31   0          0     1             \n",
       "32   0          0     1             \n",
       "33   0          0     1             \n",
       "34   0          0     1             \n",
       "35   0          0     1             \n",
       "36   0          0     1             \n",
       "37   0          0     1             \n",
       "41   0          0     1             \n",
       "55   0          0     1             \n",
       "64   0          0     1             \n",
       "70   0          0     1             \n",
       "75   0          0     1             \n",
       "76   0          0     1             \n",
       "77   0          0     1             \n",
       "210  0          0     1             \n",
       "223  0          0     1             \n",
       "332  0          0     1             \n",
       "333  0          0     1             \n",
       "413  0          0     1             \n",
       "439  0          0     1             \n",
       "440  0          0     1             \n",
       "452  0          0     1             \n",
       "457  0          0     1             \n",
       "460  0          0     1             \n",
       "461  0          0     1             \n",
       "466  0          0     1             "
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_simpletico_with_labels[df_simpletico_with_labels['none'] != df_simpletico_with_labels['no_simplification']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "4b756e41-08ef-424f-a15f-20b2baaddc94",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_simpletico_with_labels.to_csv(\"dataset/simpletico19.test.es.csv\", index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e977108e-6a53-483f-9068-d7e4a4672387",
   "metadata": {},
   "source": [
    "# Frequency Analysis of Simplification Operations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "id": "c48ecc97-d6b4-4df5-81c7-63c9fb410a77",
   "metadata": {},
   "outputs": [],
   "source": [
    "from matplotlib import pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "id": "6f790c83-ed46-4021-84a3-97da5443abad",
   "metadata": {},
   "outputs": [],
   "source": [
    "simpletico19_datasets = {'En-Dev': pd.read_csv(\"dataset/simpletico19.dev.en.csv\"),\n",
    "                         'En-Test': pd.read_csv(\"dataset/simpletico19.test.en.csv\"),\n",
    "                         'Es-Dev': pd.read_csv(\"dataset/simpletico19.dev.es.csv\"),\n",
    "                         'Es-Test': pd.read_csv(\"dataset/simpletico19.test.es.csv\")}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "id": "5db430ee-30ae-41cc-a001-e589a2d55e8d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = simpletico19_datasets['En-Dev']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "id": "2a1e836d-4d19-41f5-a136-7b41176e1278",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>stringID</th>\n",
       "      <th>original</th>\n",
       "      <th>simplification</th>\n",
       "      <th>comments</th>\n",
       "      <th>no_simplification</th>\n",
       "      <th>addition</th>\n",
       "      <th>compression</th>\n",
       "      <th>paraphrasing</th>\n",
       "      <th>splitting</th>\n",
       "      <th>none</th>\n",
       "      <th>unidentified</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>Wikipedia_handpicked_5:1933</td>\n",
       "      <td>At least 520,000 students and their families may be affected by food insecurity as a result of school closures. School lunch programmes are the second-biggest anti-hunger initiative in the United States after food stamps.</td>\n",
       "      <td>At least 520,000 students and their families may be affected by food insecurity as a result of school closures. School lunch programmes are the second-biggest anti-hunger initiative in the United States after food stamps.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>Wikipedia_handpicked_5:1931</td>\n",
       "      <td>Many children worldwide rely on free or discounted meals at schools.</td>\n",
       "      <td>Many children worldwide rely on free or discounted meals at schools.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>819</th>\n",
       "      <td>Wikivoyage_1:2354</td>\n",
       "      <td>access in and out of a town, village, or city completely blocked</td>\n",
       "      <td>access in and out of a town, village, or city completely blocked</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>820</th>\n",
       "      <td>PubMed_10:993</td>\n",
       "      <td>As the experience from the 2009 H1N1 pandemic has shown, NPIs can be a crucial component of pandemic mitigation.</td>\n",
       "      <td>As the experience from the 2009 H1N1 pandemic has shown, NPIs can be a crucial component of pandemic mitigation.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>821</th>\n",
       "      <td>Wikivoyage_1:2357</td>\n",
       "      <td>businesses, activities, and attractions closed</td>\n",
       "      <td>businesses, activities, and attractions closed</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>966</th>\n",
       "      <td>PubMed_10:865</td>\n",
       "      <td>This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test.</td>\n",
       "      <td>This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>967</th>\n",
       "      <td>Wikipedia_handpicked_5:1889</td>\n",
       "      <td>Universities and schools around the country closed.</td>\n",
       "      <td>Universities and schools around the country closed.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>968</th>\n",
       "      <td>PubMed_10:881</td>\n",
       "      <td>We also produce an annual report.</td>\n",
       "      <td>We also produce an annual report.</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>969</th>\n",
       "      <td>PubMed_9:849</td>\n",
       "      <td>What is added by this report?</td>\n",
       "      <td>What is added by this report?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>970</th>\n",
       "      <td>PubMed_9:851</td>\n",
       "      <td>What is added by this report?</td>\n",
       "      <td>What is added by this report?</td>\n",
       "      <td>NS</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>149 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                        stringID  \\\n",
       "817  Wikipedia_handpicked_5:1933   \n",
       "818  Wikipedia_handpicked_5:1931   \n",
       "819  Wikivoyage_1:2354             \n",
       "820  PubMed_10:993                 \n",
       "821  Wikivoyage_1:2357             \n",
       "..                 ...             \n",
       "966  PubMed_10:865                 \n",
       "967  Wikipedia_handpicked_5:1889   \n",
       "968  PubMed_10:881                 \n",
       "969  PubMed_9:849                  \n",
       "970  PubMed_9:851                  \n",
       "\n",
       "                                                                                                                                                                                                                          original  \\\n",
       "817  At least 520,000 students and their families may be affected by food insecurity as a result of school closures. School lunch programmes are the second-biggest anti-hunger initiative in the United States after food stamps.   \n",
       "818  Many children worldwide rely on free or discounted meals at schools.                                                                                                                                                            \n",
       "819  access in and out of a town, village, or city completely blocked                                                                                                                                                                \n",
       "820  As the experience from the 2009 H1N1 pandemic has shown, NPIs can be a crucial component of pandemic mitigation.                                                                                                                \n",
       "821  businesses, activities, and attractions closed                                                                                                                                                                                  \n",
       "..                                              ...                                                                                                                                                                                  \n",
       "966  This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test.                                                                                                       \n",
       "967  Universities and schools around the country closed.                                                                                                                                                                             \n",
       "968  We also produce an annual report.                                                                                                                                                                                               \n",
       "969  What is added by this report?                                                                                                                                                                                                   \n",
       "970  What is added by this report?                                                                                                                                                                                                   \n",
       "\n",
       "                                                                                                                                                                                                                    simplification  \\\n",
       "817  At least 520,000 students and their families may be affected by food insecurity as a result of school closures. School lunch programmes are the second-biggest anti-hunger initiative in the United States after food stamps.   \n",
       "818  Many children worldwide rely on free or discounted meals at schools.                                                                                                                                                            \n",
       "819  access in and out of a town, village, or city completely blocked                                                                                                                                                                \n",
       "820  As the experience from the 2009 H1N1 pandemic has shown, NPIs can be a crucial component of pandemic mitigation.                                                                                                                \n",
       "821  businesses, activities, and attractions closed                                                                                                                                                                                  \n",
       "..                                              ...                                                                                                                                                                                  \n",
       "966  This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test.                                                                                                       \n",
       "967  Universities and schools around the country closed.                                                                                                                                                                             \n",
       "968  We also produce an annual report.                                                                                                                                                                                               \n",
       "969  What is added by this report?                                                                                                                                                                                                   \n",
       "970  What is added by this report?                                                                                                                                                                                                   \n",
       "\n",
       "    comments  no_simplification  addition  compression  paraphrasing  \\\n",
       "817  NS       True               0         0            0              \n",
       "818  NS       True               0         0            0              \n",
       "819  NS       True               0         0            0              \n",
       "820  NS       True               0         0            0              \n",
       "821  NS       True               0         0            0              \n",
       "..   ..        ...              ..        ..           ..              \n",
       "966  NS       True               0         0            0              \n",
       "967  NS       True               0         0            0              \n",
       "968  NS       True               0         0            0              \n",
       "969  NS       True               0         0            0              \n",
       "970  NS       True               0         0            0              \n",
       "\n",
       "     splitting  none  unidentified  \n",
       "817  0          1     0             \n",
       "818  0          1     0             \n",
       "819  0          1     0             \n",
       "820  0          1     0             \n",
       "821  0          1     0             \n",
       "..  ..         ..    ..             \n",
       "966  0          1     0             \n",
       "967  0          1     0             \n",
       "968  0          1     0             \n",
       "969  0          1     0             \n",
       "970  0          1     0             \n",
       "\n",
       "[149 rows x 11 columns]"
      ]
     },
     "execution_count": 162,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['none'] == 1]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "252f9e65-00ff-4021-a388-e9d94f110a55",
   "metadata": {
    "tags": []
   },
   "source": [
    "## Distribution of Single-Operation Labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "4d329633-f224-4bff-b51f-ed6178547c21",
   "metadata": {},
   "outputs": [],
   "source": [
    "OPERATIONS = ['compression', 'paraphrasing', 'splitting', 'addition', 'none', 'unidentified']\n",
    "singlelabels_freq = {}\n",
    "for dataset_name, df_data in simpletico19_datasets.items():\n",
    "    singlelabels_freq[dataset_name] = 100. * df_data[OPERATIONS].sum() / len(df_data)\n",
    "df_singlelabels_freq = pd.DataFrame(singlelabels_freq)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "id": "f80f1c8e-f5b8-4381-b15a-0ac90f0b388c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.rcParams['font.size'] = '14'\n",
    "\n",
    "plot_singlelabels_freq = df_singlelabels_freq.plot(kind='bar', color=['#f4a582','#ca0020','#92c5de', '#0571b0'], orientation='vertical',  edgecolor='black',\n",
    "                                                   figsize=(15,5), rot=0)\n",
    "hatches = ['-'] * 6 + ['/'] * 6 + ['.'] * 6 + ['O'] * 6\n",
    "for patch, hatch in zip(plot_singlelabels_freq.patches, hatches):\n",
    "    patch.set_hatch(hatch)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "id": "a1bdf972-e649-4398-b0a9-b0ae5c7e5bea",
   "metadata": {},
   "outputs": [],
   "source": [
    "plot_singlelabels_freq.get_figure().savefig('figs/singlelabel_operations_frequency.pdf', dpi=300, bbox_inches='tight')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4358749c-1070-4072-aa84-7a5ee10f2eb0",
   "metadata": {},
   "source": [
    "## Distribution of Multi-Operation Labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "11de00dd-0d8e-4006-9961-318888b2d829",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.preprocessing import MultiLabelBinarizer\n",
    "from more_itertools import powerset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "2009a266-d460-47dd-b473-9954d02357aa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['addition', 'compression', 'none', 'paraphrasing', 'splitting',\n",
       "       'unidentified'], dtype=object)"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mlb = MultiLabelBinarizer()\n",
    "mlb.fit([OPERATIONS])\n",
    "mlb.classes_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "f4e9c35a-5769-4aaf-b6b1-f3249c568fc1",
   "metadata": {},
   "outputs": [],
   "source": [
    "multiop_labels = list(powerset(OPERATIONS))\n",
    "multiop_names = ['compression\\n(only)', 'paraphrasing\\n(only)', 'splitting\\n(only)', 'addition\\n(only)', \n",
    "                 'compression\\nparaphrasing', 'compression\\nsplitting', 'compression\\naddition', 'paraphrasing\\nsplitting', 'paraphrasing\\naddition', 'splitting\\naddition',\n",
    "                 'compression\\nparaphrasing\\nsplitting', 'compression\\nparaphrasing\\naddition', 'paraphrasing\\nsplitting\\naddition',\n",
    "                 'compression\\nparaphrasing\\nsplitting\\naddition']\n",
    "multilabels_freq = {}\n",
    "for dataset_name, df_data in simpletico19_datasets.items():    \n",
    "    df_data['compression\\n(only)'] = ((df_data['compression'] == 1) & \n",
    "                                          (df_data['paraphrasing'] == 0) & \n",
    "                                          (df_data['splitting'] == 0) & \n",
    "                                          (df_data['addition'] == 0) &\n",
    "                                          (df_data['none'] == 0)).astype(int)\n",
    "    df_data['paraphrasing\\n(only)'] = ((df_data['compression'] == 0) & \n",
    "                                          (df_data['paraphrasing'] == 1) & \n",
    "                                          (df_data['splitting'] == 0) & \n",
    "                                          (df_data['addition'] == 0) &\n",
    "                                          (df_data['none'] == 0)).astype(int)\n",
    "    df_data['splitting\\n(only)'] = ((df_data['compression'] == 0) & \n",
    "                                          (df_data['paraphrasing'] == 0) & \n",
    "                                          (df_data['splitting'] == 1) & \n",
    "                                          (df_data['addition'] == 0) &\n",
    "                                          (df_data['none'] == 0)).astype(int)\n",
    "    df_data['addition\\n(only)'] = ((df_data['compression'] == 0) & \n",
    "                                          (df_data['paraphrasing'] == 0) & \n",
    "                                          (df_data['splitting'] == 0) & \n",
    "                                          (df_data['addition'] == 1) &\n",
    "                                          (df_data['none'] == 0)).astype(int)\n",
    "    \n",
    "    df_data['compression\\nparaphrasing'] = ((df_data['compression'] == 1) & \n",
    "                                                (df_data['paraphrasing'] == 1) & \n",
    "                                                (df_data['splitting'] == 0) &\n",
    "                                                (df_data['addition'] == 0) &\n",
    "                                                (df_data['none'] == 0)).astype(int)\n",
    "    df_data['compression\\nsplitting'] = ((df_data['compression'] == 1) & \n",
    "                                             (df_data['paraphrasing'] == 0) & \n",
    "                                             (df_data['splitting'] == 1) & \n",
    "                                             (df_data['addition'] == 0) &\n",
    "                                             (df_data['none'] == 0)).astype(int)\n",
    "    df_data['compression\\naddition'] = ((df_data['compression'] == 1) & \n",
    "                                             (df_data['paraphrasing'] == 0) & \n",
    "                                             (df_data['splitting'] == 0) & \n",
    "                                             (df_data['addition'] == 1) &\n",
    "                                             (df_data['none'] == 0)).astype(int)\n",
    "    df_data['paraphrasing\\nsplitting'] = ((df_data['compression'] == 0) & \n",
    "                                              (df_data['paraphrasing'] == 1) & \n",
    "                                              (df_data['splitting'] == 1) &\n",
    "                                              (df_data['addition'] == 0) &\n",
    "                                              (df_data['none'] == 0)).astype(int)\n",
    "    df_data['paraphrasing\\naddition'] = ((df_data['compression'] == 0) & \n",
    "                                              (df_data['paraphrasing'] == 1) & \n",
    "                                              (df_data['splitting'] == 0) &\n",
    "                                              (df_data['addition'] == 1) &\n",
    "                                              (df_data['none'] == 0)).astype(int)\n",
    "    df_data['splitting\\naddition'] = ((df_data['compression'] == 0) & \n",
    "                                              (df_data['paraphrasing'] == 0) & \n",
    "                                              (df_data['splitting'] == 1) &\n",
    "                                              (df_data['addition'] == 1) &\n",
    "                                              (df_data['none'] == 0)).astype(int)\n",
    "    \n",
    "    df_data['compression\\nparaphrasing\\nsplitting'] = ((df_data['compression'] == 1) & \n",
    "                                                           (df_data['paraphrasing'] == 1) & \n",
    "                                                           (df_data['splitting'] == 1) &\n",
    "                                                           (df_data['addition'] == 0) &\n",
    "                                                           (df_data['none'] == 0)).astype(int)\n",
    "    df_data['compression\\nparaphrasing\\naddition'] = ((df_data['compression'] == 1) & \n",
    "                                                           (df_data['paraphrasing'] == 1) & \n",
    "                                                           (df_data['splitting'] == 0) &\n",
    "                                                           (df_data['addition'] == 1) &\n",
    "                                                           (df_data['none'] == 0)).astype(int)\n",
    "    df_data['paraphrasing\\nsplitting\\naddition'] = ((df_data['compression'] == 0) & \n",
    "                                                           (df_data['paraphrasing'] == 1) & \n",
    "                                                           (df_data['splitting'] == 1) &\n",
    "                                                           (df_data['addition'] == 1) &\n",
    "                                                           (df_data['none'] == 0)).astype(int)\n",
    "    df_data['compression\\nparaphrasing\\nsplitting\\naddition'] = ((df_data['compression'] == 1) & \n",
    "                                                                     (df_data['paraphrasing'] == 1) & \n",
    "                                                                     (df_data['splitting'] == 1) &\n",
    "                                                                     (df_data['addition'] == 1) &\n",
    "                                                                     (df_data['none'] == 0)).astype(int)\n",
    "    \n",
    "    multilabels_freq[dataset_name] = 100. * df_data[multiop_names + ['none', 'unidentified']].sum() / len(df_data)\n",
    "df_multilabels_freq = pd.DataFrame(multilabels_freq)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "c192f91d-503c-46c9-972e-2dc641496a58",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1800x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_multilabels_freq = df_multilabels_freq.plot(kind='bar', color=['#66c2a5','#fc8d62','#8da0cb'], orientation='vertical',  edgecolor='black', figsize=(25,4), rot=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6d789a8c-605f-4162-8284-fffa7e4d7966",
   "metadata": {},
   "outputs": [],
   "source": [
    "# plot_multilabels_freq.get_figure().savefig('multilabel_operations_frequency.pdf', dpi=300, bbox_inches='tight')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ats",
   "language": "python",
   "name": "ats"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
